psychiatry
(7)
Scott Alexander Built a Public Square for People Who Prefer Footnotes to Factions
For more than a decade, the psychiatrist behind Slate Star Codex and Astral Codex Ten has made uncertainty readable - then invited the readers to argue back.
Craig Hopkinson Turns Deep Science Into Medicines That Reach People
A doctor by training who now runs research, development and medical affairs at one of neuroscience's most watched biopharma companies - and keeps the patient at the center of every decision.
Shareh Ghani Turned Behavioral Health Into a Data Problem Worth Solving
From the ACT teams of Maricopa County to the C-suite of a national managed care company, Shareh Ghani built a career on a stubborn idea: that good care and good data are the same project.
Christopher Gaeta
Christopher Gaeta is the founder and CEO of InSite Health, a venture-backed behavioral health company building what he calls a K-12 wellness operating system: one integrated platform that bundles mental health screenings, on-site therapy and psychiatric care for school districts that were otherwise stitching together six or more separate vendors. A 2023 Swarthmore College graduate and former co-captain of the golf team, he previously ran the campus-wellness company Grapefruit to 250,000 patients and worked as a healthcare venture investor before turning operator. Business Insider named him a top Gen Z venture capitalist, and he aims to build the nation's largest K-12 wellness platform by 2030.
Ilise Lombardo
Ilise Lombardo is the CEO of Noema Pharma, a Basel-based clinical-stage biotech advancing treatments for central nervous system disorders. A Yale-trained psychiatrist with a Cambridge M.Phil and a Brown degree, she spent two decades in clinical practice and academia before co-founding Arvelle Therapeutics, which sold to Angelini Pharma for roughly $1 billion in 2021. She now steers Noema's pipeline of Phase 2 programs targeting Tourette syndrome, trigeminal neuralgia, tuberous sclerosis seizures and menopause-related CNS symptoms.
Brad Kittredge
Brad Kittredge is the co-founder and CEO of Brightside Health, a San Francisco-based telemental health platform serving 135 million covered lives across commercial insurance, Medicare, and Medicaid. Driven by his father's decade-long struggle to find effective depression treatment, Kittredge built Brightside from a two-day old Stripe notification into the first telepsychiatry company to achieve 100% national Medicare Part B coverage. Before Brightside, he led product teams at 23andMe and Lantern, and built ComplexDx - later acquired by 23andMe. He holds an MBA, MPH, MA in International Affairs, and a BA in Psychology, all from UC Berkeley and UC San Diego.
Yash Patel
Yash M. Patel is the Co-Founder and CEO of Legion Health, a San Francisco-based AI-native mental health platform that delivers insurance-covered psychiatric care via telehealth. A Princeton mathematics graduate (2018) and Y Combinator alum (S21), Yash previously worked as a healthcare policy analyst at the Congressional Budget Office and as a research assistant at Harvard Medical School. Motivated in part by his experience caregiving for his father, he co-founded Legion Health in 2021 alongside Princeton classmates Arthur MacWaters and Daniel Wilson. The company has raised over $10M, and in April 2026 became the first startup to receive regulatory authorization to let AI prescribe psychiatric medications.